Cleary, Paul Weiss act on Takeda’s $5.2 bln pharma acquisition
BY Raj Gunashekar, Reuters |
Cleary Gottlieb Steen & Hamilton has served as legal counsel to Japan‘s Takeda Pharmaceutical on a $5.2 billion deal to acquire U.S.-based rare cancer drugmaker Ariad Pharmaceuticals, represented by Paul, Weiss, Rifkind, Wharton & Garrison.